Skip to main content
. 2012 Apr 18;2012(4):CD003916. doi: 10.1002/14651858.CD003916.pub4

Comparison 9. EBRT vs. No EBRT: Adverse effects.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Acute toxicity (all grades) 2 1328 Risk Ratio (M‐H, Random, 95% CI) 2.97 [1.49, 5.92]
2 Severe acute toxicity (G3/4) 2 1328 Risk Ratio (M‐H, Random, 95% CI) 4.68 [1.35, 16.16]
3 Late toxicity (all grades) 2   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
4 Severe late toxicity (G3/4) 6 3501 Risk Ratio (M‐H, Random, 95% CI) 2.58 [1.61, 4.11]
4.1 EBRT vs. no additional treatment 2 1106 Risk Ratio (M‐H, Random, 95% CI) 6.74 [1.53, 29.74]
4.2 EBRT vs. no additional treatment (VBT balanced across groups) 2 1445 Risk Ratio (M‐H, Random, 95% CI) 2.19 [1.25, 3.85]
4.3 EBRT vs. VBT 2 950 Risk Ratio (M‐H, Random, 95% CI) 2.78 [1.01, 7.67]